InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,616.30
(
-0.31%
)
US TECH 100
19,990.00
(
-0.64%
)
Dow Jones
39,740.75
(
0.05%
)
Brent Oil
84.54
(
-0.61%
)
Bitcoin
57,785.30
(
0.05%
)
Post# of 567
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Camaro1093

Send PM Follow Ignore
Followers 14
Posts 1226
Boards Moderated 1
Alias Born 08/16/2009

Camaro1093

Re: None

Friday, 12/11/2009 12:21:36 PM

Friday, December 11, 2009 12:21:36 PM

Post# of 567
New stock to watch: ANDS

Interim RVR and Safety data should be out for ANA-598 by year end, according to the company. However, it was brought to my attention that it is only for the 200mg cohort, the other higher dosage cohorts cannot be dosed until the 200mg cohort has been proven for safety, due to 19% of patients getting a rash when taking the higher dosage.

GLTA.

Visit my biotech investing board!: investorshub.advfn.com/boards/board.aspx?board_id=16653



GLTA.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up